These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan. Herbort CP; Mochizuki M Int Ophthalmol; 2007; 27(2-3):67-79. PubMed ID: 17468832 [TBL] [Abstract][Full Text] [Related]
11. Integrated omics analysis of sweat reveals an aberrant amino acid metabolism pathway in Vogt-Koyanagi-Harada disease. Cui X; Su G; Zhang L; Yi S; Cao Q; Zhou C; Kijlstra A; Yang P Clin Exp Immunol; 2020 Jun; 200(3):250-259. PubMed ID: 32222072 [TBL] [Abstract][Full Text] [Related]
12. Plasma metabolomics study of Vogt-Koyanagi-Harada disease identifies potential diagnostic biomarkers. Chen L; Chang R; Pan S; Xu J; Cao Q; Su G; Zhou C; Kijlstra A; Yang P Exp Eye Res; 2020 Jul; 196():108070. PubMed ID: 32439397 [TBL] [Abstract][Full Text] [Related]
13. New insights into Vogt-Koyanagi-Harada disease. Damico FM; Bezerra FT; Silva GC; Gasparin F; Yamamoto JH Arq Bras Oftalmol; 2009; 72(3):413-20. PubMed ID: 19668980 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients. Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067 [TBL] [Abstract][Full Text] [Related]
15. Characteristics, Upon Presentation, of a Cohort of Patients with Vogt-Koyanagi-Harada Disease in Puerto Rico. Barquet V; Rodríguez E; Fantauzzi A; Ortíz JC; Ulloa-Padilla JP; Vilá-Delgado MS; Fernández CJ; Almodóvar JC; Santos C; Oliver AL P R Health Sci J; 2021 Nov; 40(4):168-173. PubMed ID: 35077075 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284 [TBL] [Abstract][Full Text] [Related]
17. Vogt Koyanagi Harada Syndrome mimicking multiple sclerosis: A case report and review of the literature. Algahtani H; Shirah B; Algahtani R; Alkahtani A; Alwadie S Mult Scler Relat Disord; 2017 Feb; 12():44-48. PubMed ID: 28283106 [TBL] [Abstract][Full Text] [Related]
18. Clinical Manifestations and Treatment of Vogt-Koyanagi-Harada Disease during Pregnancy and after Birth: A Case Report. Sanchez-Vicente JL; Moruno-Rodríguez A; De Las Morenas-Iglesias J; Gonzalez-Jauregui B; Franco-Ruedas C; Lechon-Caballero B; Talego-Sancha A; Rueda-Rueda T; Del Estad-Cabello A; López-Herrero F Ocul Immunol Inflamm; 2023 May; 31(4):830-837. PubMed ID: 35404732 [TBL] [Abstract][Full Text] [Related]
19. Applicability of the 2001 revised diagnostic criteria in Brazilian Vogt-Koyanagi-Harada disease patients. Cardoso IH; Zajdenweber ME; Muccioli C; Fimamor LP; Belfort R Arq Bras Oftalmol; 2008; 71(1):67-70. PubMed ID: 18408841 [TBL] [Abstract][Full Text] [Related]
20. Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area. Herbort CP; Tugal-Tutkun I; Khairallah M; Abu El Asrar AM; Pavésio CE; Soheilian M Int Ophthalmol; 2020 Sep; 40(9):2423-2433. PubMed ID: 32418076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]